PubMed Health⌕ Search

Biomedical subjects

L M Metz

Publications and source records attributed to L M Metz.

27 records · Page 2Linked to original sources

Urinary tract infections may trigger relapse in multiple sclerosis.

Multiple Sclerosis (MS), a demyelinating disease of the central nervous system, is the most common neurological disease affecting young adults in North America and, in the majority of cases, is associated with accumulating disability. Urinary tract dysfunction affects up to 90% of the MS population, and urinary tract infections are encountered in up to 74% of the tested population. Viral infections have previously been shown to trigger acute exacerbation and it is our experience that urinary tract infection also commonly precedes relapse, and, when recurrent, is associated with neurologic progression. We present three case studies from our MS Clinic where recurrent UTI was associated with acute exacerbation and neurologic progression refractory to intravenous steroid treatment. Interferons, protein signaling molecules, have recently been found to play a role in acute exacerbation and disease progression in individuals with MS. Viral infections induce interferon release which may activate T cells to produce gamma-interferon. Interferon-gamma precipitates relapse and stimulates production of tumour necrosis factor-alpha, a cytokine directly toxic to oligodendrocytes. Bacterial infections similarly induce interferon release and may activate immune pathways that result in MS exacerbation and neurologic progression.

Acute Disease↗

Depression in multiple sclerosis.

BACKGROUND: An association between multiple sclerosis (MS) and depression has been recognized for several decades and has attracted considerable attention in research. However, there are considerable gaps in the current state of knowledge. In this review, the literature concerned with: (1) the burden of depression in MS; (2) the etiology of depression in MS, and (3) the treatment of depression in MS are critically examined. METHOD: The literature review utilized Medline (1966-1996), and was supplemented by citations extracted from the papers originally uncovered. RESULTS: Numerous studies have identified elevated depressive symptom scores in MS patients relative to nonclinical and (some) clinical control groups. Furthermore, studies of depressive disorders have clearly documented elevated prevalence rates in MS samples. The literature does not identify any specific pattern of neurological involvement as being consistently associated with depressive symptoms or disorders. Psychosocial risk factors contribute to the etiology of depression in MS, but the relative importance of various risk factors is yet to be determined. A single randomized controlled clinical trial, and additional anecdotal evidence, suggests that antidepressant pharmacotherapy is effective for depressive disorders in MS. CONCLUSIONS: Future epidemiological studies should not restrict their evaluation of risk factors to those specific factors that are closely related to the disease process. In particular, future researchers should resist the temptation to focus too exclusively on neuropathology. Biological, psychological and social risk factors are all potentially important. Additional empirical efforts to refine the various treatment approaches would be a welcome addition to this literature.

Antidepressive Agents↗

An analysis of the frequency of Sjogren's syndrome in a population of multiple sclerosis patients.

We have studied 42 unselected patients with a clinical diagnosis of multiple sclerosis (MS) for clinical and laboratory features of Sjogren's syndrome (SS). The MS patients in this study had similar demographic/epidemiologic features as those previously reported in the literature. The most striking features of the MS patients suggesting a SS diathesis was the presence of dry eyes (xeropthalmia) in six (14%). Although 2/6 of the symptomatic patients and 6/36 of the asymptomatic patients had abnormal tear production (Schirmer's test) this was accounted for by the concomitant use of anti-cholinergic medication. None of the MS patients had autoantibodies (SS-A/Ro, SS-B/La, rheumatoid factor) thought to be characteristic of SS. We conclude that SS, either in isolation or occurring in combination with MS, is uncommon in an MS outpatient setting.

Adult↗

Responding to reported clusters of common diseases: the case of multiple sclerosis.

Reports of disease clustering are becoming ever more common, and there is increasing pressure on public health agencies to respond rapidly and appropriately to these reports. We investigated a cluster of five cases of MS occurring in a small multidisciplinary hospital department. Data were collected by a variety of methods, including measurement and description of the workplace, completion of survey instruments by department staff, and construction of case histories of persons with MS. The results indicated that the department comprised a high-risk population and that only one case of MS could have any possible etiologic significance. Investigators should consider a number of factors when evaluating disease clusters, including the accuracy of diagnosis, the induction period and cause of the disease, and possible biases in the population at risk. Additionally, boundaries should not encircle the cases that led to identification of the cluster and should reflect environmental significance.

Adult↗